Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Twinlab

This article was originally published in The Tan Sheet

Executive Summary

Firm's common stock will be transferred to NASDAQ SmallCap Market effective Sept. 30, Hauppauge, N.Y.-based company announces Sept. 18. NASDAQ approved firm's application to move stock from National Market after setting Sept. 16 deadline for Twinlab to reply regarding its failure to meet market's $1 minimum listing price (1"The Tan Sheet" Aug. 5, 2002, p. 11)...

You may also be interested in...



Business & Financial News In Brief

Weider Nutrition brand divestiture: Optimum Nutrition subsidiary American Body Building picks up Weider's Science Foods, American Body Building brands in transaction that closed July 26. Deal affects 75-100 SKUs - primarily drinks and some bars - with total annual sales of slightly more than $20 mil. Transaction's total cost was not released, but final price includes roughly $5.7 mil. cash, assumption of approximately $250,000 mortgage on Walterborough, S.C. beverage manufacturing facility that was part of the deal. Acquisition gives Optimum Nutrition expanded line of beverages to complement current offerings of powders, capsules, bars. Weider says it will use net proceeds to reduce long-term debt, and transaction will negatively impact FY 2002 pre-tax financials by $8.7 mil.-$9.5 mil. Sale is part of Weider's effort to focus resources on Schiff Specialty Nutrition, Active Nutrition and Haleko business units...

Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says

The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.

The Aspirin Test For AI?

US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094570

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel